# A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa

> **NCT01528306** · PHASE2 · WITHDRAWN · sponsor: **Healthpoint**

## Conditions studied

- Dystrophic Epidermolysis Bullosa

## Interventions

- **BIOLOGICAL:** HP802-247
- **OTHER:** Placebo

## Key facts

- **NCT ID:** NCT01528306
- **Lead sponsor:** Healthpoint
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2012-03
- **Primary completion:** 2013-03
- **Final completion:** 2013-07
- **Target enrollment:** 0 (ACTUAL)
- **Last updated:** 2012-05-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01528306

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01528306, "A Pilot Study of HP802-247 in Dystrophic Epidermolysis Bullosa". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT01528306. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*